deepeye Medical develops AI-driven software to improve treatment planning for retinal diseases. Their mission is to empower ophthalmology by providing additional insights into treatment data for patients with retinal eye diseases, enabling informed decisions and better vision.

The company's first regulated medical device, deepeye® TPS (CE marked, Class IIa), is an AI therapy assistant that provides a second reading of OCT scans, visualizes disease activity, predicts treatment need over the next 12 months, and integrates with common OCT systems. They also offer a flexible AI platform and analytic services for researchers and clinical trial teams.

Headquarters: Paul-Heyse-Str. 2-4, 80336 Munich, Germany. Partnerships include Topcon, Heidelberg, Roche, and Bayer. Contact: [email protected]. Careers and open roles listed at the company careers page.